A carregar...
The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion
PURPOSE: The purpose of this study was to evaluate the in-use physicochemical and biological stability of the Sandoz rituximab biosimilar, marketed under the trade names Rixathon® and Riximyo® in the European Union, upon preparation for intravenous infusion. METHODS: Three batches of Rixathon®/Rixim...
Na minha lista:
| Publicado no: | J Oncol Pharm Pract |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348458/ https://ncbi.nlm.nih.gov/pubmed/28950806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155217731506 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|